glp 1 agonist dementia GLP-1R agonists protect against Alzheimer's disease by rewiring energy regulation CKD Dementia Risk Reduced with
Description
The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4

Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J

Retrospective review of the incidence of monitoring blood glucose levels in patients receiving corticosteroids with systemic anticancer therapy

Lancet Title: Tirzepatide Once Weekly for the Treatment of Obesity in People With Type 2 Diabetes (Surmount-2): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial

Meyer-Gerspach, A

Many countries factor WHO guidelines into their health policies
